Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Emory University
Centre Francois Baclesse
University of Wisconsin, Madison
Eastern Cooperative Oncology Group
University of Pisa
University of Colorado, Denver
AstraZeneca
Memorial Sloan Kettering Cancer Center